Browse
Submit Data
Databases
API
Help

Dataset Information

9 Views

8 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1003

Genetics and Molecular Pathology, SA Pathology

ABSTRACT: Organisation EGAO00000000300

PROVIDER: EGAO00000000300 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Publications

A comparative analysis of algorithms for somatic SNV detection in cancer.

Roberts Nicola D ND Kortschak R Daniel RD Parker Wendy T WT Schreiber Andreas W AW Branford Susan S Scott Hamish S HS Glonek Garique G Adelson David L DL

Bioinformatics (Oxford, England) 20130709 18

<h4>Motivation</h4>With the advent of relatively affordable high-throughput technologies, DNA sequencing of cancers is now common practice in cancer research projects and will be increasingly used in clinical practice to inform diagnosis and treatment. Somatic (cancer-only) single nucleotide variants (SNVs) are the simplest class of mutation, yet their identification in DNA sequencing data is confounded by germline polymorphisms, tumour heterogeneity and sequencing and analysis errors. Four rece ...[more]

PMID: 23842810

Similar Datasets

Centre for Cancer Biology, SA Pathology

Project description:Organisation EGAO00000000303

| EGAO00000000303 | EGA

The South Australian Cancer Research Biobank and SA Pathology

Project description:Organisation EGAO00000000302

| EGAO00000000302 | EGA

Project description:Organisation EGAO00000001078

| EGAO00000001078 | EGA

Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes.

Project description:The hepatorenal fibrocystic (HRFC) syndromes are a heterogeneous group of severe monogenic conditions that may be detected before birth. Commonly, HRFC syndromes present in the neonatal and paediatric age, with consistent developmental abnormalities mostly involving the liver and kidney. The changes include the proliferation and dilatation of epithelial ducts in these tissues with abnormal deposition of extracellular matrix. In this review, we examine the clinical features and differential diagnoses of this group of syndromes, including autosomal recessive polycystic kidney disease (ARPKD), juvenile nephronophthisis (NPHP), Meckel-Gruber syndrome (MKS), Bardet-Biedl syndrome (BBS), and Jeune asphyxiating thoracic dystrophy (JATD). Extrahepatic manifestations include mostly bone and central nervous system abnormalities, dysmorphic features, and developmental delay. Previously, it has been suggested that ARPKD, JATD, and Ellis-van Creveld syndrome (EvC) may arise from defects in differentiation in a common developmental pathway. We review recent molecular advances in the recessive HRFC syndromes and discuss this hypothesis.

| S-EPMC1735460 | biostudies-other

Northern Ireland Molecular Pathology Laboratory

Project description:Organisation EGAO00000000322

| EGAO00000000322 | EGA

ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology

Project description:Organisation EGAO00000000301

| EGAO00000000301 | EGA

MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.

Project description:Pituitary adenomas are a common feature of a subset of endocrine neoplasia syndromes, which have otherwise highly variable disease manifestations. We provide here a review of the clinical features and human molecular genetics of multiple endocrine neoplasia (MEN) type 1 and 4 (MEN1 and MEN4, respectively) and Carney complex (CNC). MEN1, MEN4, and CNC are hereditary autosomal dominant syndromes that can present with pituitary adenomas. MEN1 is caused by inactivating mutations in the MEN1 gene, whose product menin is involved in multiple intracellular pathways contributing to transcriptional control and cell proliferation. MEN1 clinical features include primary hyperparathyroidism, pancreatic neuroendocrine tumours and prolactinomas as well as other pituitary adenomas. A subset of patients with pituitary adenomas and other MEN1 features have mutations in the CDKN1B gene; their disease has been called MEN4. Inactivating mutations in the type 1α regulatory subunit of protein kinase A (PKA; the PRKAR1A gene), that lead to dysregulation and activation of the PKA pathway, are the main genetic cause of CNC, which is clinically characterised by primary pigmented nodular adrenocortical disease, spotty skin pigmentation (lentigines), cardiac and other myxomas and acromegaly due to somatotropinomas or somatotrope hyperplasia.

| S-EPMC4497946 | biostudies-literature

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Project description:Hereditary ovarian cancer accounts for at least 5% of the estimated 22,000 new cases of this disease during 2009. During this same time, over 15,000 will die from malignancy ascribed to ovarian origin. The bulk of these hereditary cases fits the hereditary breast-ovarian cancer syndrome, while virtually all of the remainder will be consonant with the Lynch syndrome, disorders which are autosomal dominantly inherited. Advances in molecular genetics have led to the identification of BRCA1 and BRCA2 gene mutations which predispose to the hereditary breast-ovarian cancer syndrome, and mutations in mismatch repair genes, the most common of which are MSH2 and MLH1, which predispose to Lynch syndrome. These discoveries enable relatively certain diagnosis, limited only by their variable penetrance, so that identification of mutation carriers through a comprehensive cancer family history might be possible. This paper reviews the subject of hereditary ovarian cancer, with particular attention to its molecular genetic basis, its pathology, and its phenotypic/genotypic heterogeneity.

| S-EPMC2778287 | biostudies-literature

VIB Department of Molecular Genetics

Project description:Organisation EGAO00000000042

| EGAO00000000042 | EGA

Max-Planck-Institute for Molecular Genetics

Project description:Organisation EGAO00000000748

| EGAO00000000748 | EGA